Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 10, 2013 05:15 ET | Source: Genetic Technologies

Genetic Technologies Announces U.S. Patent Office Allows First Patent for ImmunAid

MELBOURNE, AUSTRALIA--(Marketwired - Jul 10, 2013) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to announce that ImmunAid Limited, in which GTG holds a 45% direct equity...
July 01, 2013 07:00 ET | Source: Genetic Technologies

Genetic Technologies Announces Record Number of BREVAGen(TM) Tests

MELBOURNE, AUSTRALIA--(Marketwired - Jul 1, 2013) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) announces that a record number of BREVAGen™ test samples were received during the...
June 24, 2013 05:15 ET | Source: Genetic Technologies

Genetic Technologies Settles Its Dispute With Ingelheim, Germany-Based Bioscientia Institute for Medical Diagnostics

MELBOURNE, AUSTRALIA--(Marketwired - Jun 24, 2013) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to announce that it has now settled its dispute with Bioscientia Institute for...
June 24, 2013 05:15 ET | Source: Genetic Technologies

Genetic Technologies Announces Independent Clinical Validation Study in Support of the Utilization of BREVAGen(TM)

MELBOURNE, AUSTRALIA--(Marketwired - Jun 24, 2013) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) announces the publication online in Breast Cancer Research & Treatment on Friday,...
June 19, 2013 05:15 ET | Source: Genetic Technologies

Genetic Technologies Executes Agreement With Further Nationwide Provider Network for BREVAGen(TM)

MELBOURNE, AUSTRALIA--(Marketwired - Jun 19, 2013) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to announce that through its wholly-owned subsidiary Phenogen Sciences Inc. it...
June 17, 2013 08:00 ET | Source: Genetic Technologies

Genetic Technologies Provides U.S. Gene Patenting Update

MELBOURNE, AUSTRALIA--(Marketwired - Jun 17, 2013) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) provides an update to the Market on its position following the U.S. Supreme Court's...
May 22, 2013 06:00 ET | Source: Alchemia

Alchemia Limited Provides Company Update

BRISBANE, AUSTRALIA--(Marketwired - May 22, 2013) - $2.4M fondaparinux profit share recorded for quarter ending 31 March 2013 Establishment of a...
May 20, 2013 06:00 ET | Source: Genetic Technologies

Genetic Technologies Executes Agreement With MultiPlan, Inc., a Nationwide Provider Network

MELBOURNE, AUSTRALIA--(Marketwired - May 20, 2013) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to announce that, through its wholly-owned subsidiary Phenogen Sciences Inc.,...
May 16, 2013 06:00 ET | Source: Vital Therapies

Vital Therapies, Inc. Adds Two New Board Members

SAN DIEGO, CA--(Marketwired - May 16, 2013) - Vital Therapies, Inc., a development stage biotechnology company focused on developing the first bio-artificial liver for life-threatening acute liver...
May 09, 2013 17:14 ET | Source: Sunshine Heart

Sunshine Heart, Inc. gibt in europäischer Studie für Anwendungsbeobachtung die erste Implantation des 'C-Pulse-System' bekannt

EDEN PRAIRIE, MN--(Marketwired - May 9, 2013) - Sunshine Heart, Inc. (NASDAQ: SSH) hat heute in einer multizentrischen Studie die erste Implantation des OPTIONS HF C-Pulse System bekannt gegeben....